Do you want to learn more about the FACTS related to the recent ban of TiO2 (E171) in Europe for food uses and the potential impact this could have globally on pharmaceuticals?
Read MoreIn September 2021, a Novel Excipient Review Pilot Program was launched in the US that would allow excipient manufacturers to get their novel excipient approved for use in pharmaceuticals prior to use.
Read MoreFDA launches new Pilot Program for Novel Excipient Review which will encourage innovation in drug and excipient development!!
Read More